Apple Announces Food & Drug Administration Approval For Its Apple Watch Series 4

Apple recently announced that the U.S. Food and Drug Administration (FDA) has its Apple Watch Series 4—a smart watch that can perform electrocardiograms (ECGs) with a new app. By detecting atrial fibrillation, as well as allowing the ability consumers to contact emergency services in the event of a fall, the app takes a large step in granting greater accessibility to care.

According to statements from Apple, the ECG readings take about 30 seconds, and can also be sent to clinical professionals through Apple Health Records or a PDF. Apple leadership also remarked that the app is the first . . .